# Foseco India share price today (Foseco India Ltd, NSE: FOSECOIND)

> Foseco India share price today: ₹5,969.00 at the NSE close on 4 November 2026, up 8.5% in a year. Foseco India (NSE: FOSECOIND) is worth ₹4,498 crore, trades at a P/E of 51.2 and has closed between ₹4,386.30 and ₹6,677.50 over the past 52 weeks. > Foseco India Ltd's results are improving, and its P/E is near the top of its own history, higher than 95% of past readings. FOSECOIND · Chemicals - Organic · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/foseco-india-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹5,969.00 (+8.5% in a year)
- P/E: 51.2× (higher than 95% of the last 10 years)
- Revenue (Jun 2026): ₹182 Cr (+15.9% on a year ago)
- Profit (Jun 2026): ₹23.0 Cr (+4.5% on a year ago)
- Operating margin: 18.0% (+1.0 points on a year ago)
- ROCE: 16%, FY25
- ROIC: 12.8%, against a 12.0% cost of capital: +0.8 points

The main question: results are strong, and the P/E is higher than 95% of its own history. ## What is the Foseco India share price today? Foseco India Ltd's share price was ₹5,969.00 at the close on 4 November 2026. It has been rising for 18 weeks. That is 8.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹4,386 and ₹6,678, and at that close it sat 69% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 17 weeks in a row. Over the last 11 years the share price moved +409% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Foseco India this quarter? Two changes stood out: revenue up on a year earlier for 9 quarters in a row (every quarter we can compare) and highest quarterly revenue in 13 quarters. 1. Revenue up on a year earlier for 9 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹182 crore, +15.9% on a year earlier. 2. Highest quarterly revenue in 13 quarters Revenue of ₹182 crore in the June 2026 quarter is the highest of the last 13 quarters. ## What are Foseco India's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Foseco India reported revenue of ₹182 crore, up 15.9% from ₹157 crore a year earlier, and a profit of ₹23.0 crore, up 4.5% from ₹22.0 crore. ### Foseco India results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹182 crore | ₹157 crore | +15.9% |
| Profit | ₹23.0 crore | ₹22.0 crore | +4.5% |
| Earnings per share | ₹30.33 | ₹33.71 | −10.0% |
| Operating margin | 18.0% | 17.0% | +1.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Foseco India share price history? Foseco India closed at ₹5,969.00 on 4 November 2026, up 8.5% from ₹5,503.00 a year earlier (7 November 2025) and up 300.8% over five years. Its highest weekly close since March 2016 was ₹6,677.50 on 18 September 2026. ### Foseco India share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹5,863.50 | +1.8% |
| 1 month ago · 1 Oct 2026 | ₹6,382.50 | −6.5% |
| 6 months ago · 8 May 2026 | ₹5,051.60 | +18.2% |
| 1 year ago · 7 Nov 2025 | ₹5,503.00 | +8.5% |
| 3 years ago · 3 Nov 2023 | ₹3,384.40 | +76.4% |
| 5 years ago · 4 Nov 2021 | ₹1,489.15 | +300.8% |
| 10 years ago · 4 Nov 2016 | ₹1,398.65 | +326.8% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹1,173.80 | +408.5% |
| Highest weekly close since March 2016, also the 52-week high · 18 Sep 2026 | ₹6,677.50 | −10.6% |
| Lowest weekly close since March 2016 · 27 Mar 2020 | ₹861.60 | +592.8% |
| 52-week low (weekly close) · 1 Feb 2026 | ₹4,386.30 | +36.1% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (561 weekly closes from 11 March 2016 to 4 November 2026.)

## What is the latest news on Foseco India? 4 Nov 2026: Foseco India closed at ₹5,969.00, up 1.8% on the week and down 6.5% on the month. Results for April to June 2026: Revenue up 15.9% and profit up 4.5% on a year earlier. ### Earlier

- 3 Jun 2026: ex-date for a dividend of ₹25 a share. ## What dividend does Foseco India pay? Foseco India paid ₹25 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.42% at the ₹5,969.00 close on 4 November 2026. The last was a dividend of ₹25 a share, ex-date 3 June 2026. ### Foseco India dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 3 Jun 2026 | ₹25 | Dividend |
| 14 May 2025 | ₹25 | Dividend |
| 4 Jun 2024 | ₹25 | Dividend |
| 17 May 2023 | ₹40 | Dividend + Special |
| 2 May 2022 | ₹25 | Dividend |
| 11 Jun 2021 | ₹10 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Foseco India Ltd paid out 25% of its profit as dividends in FY25, and it paid a dividend in each of its last 12 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## What did Foseco India management say on the latest results call? Foseco India's management made 0 promises we could check against what it later reported. (Our read after the April to June 2026 results, written 10 October 2026.)

## What is the future of Foseco India? What is changing in the business? What is changing at Foseco India, from the latest results and calls: acquired crucible platform and pending mehsana undertaking. - Acquired crucible platform. The completed MCIL acquisition expands the operating perimeter, but shareholder benefit must be measured after dilution and integration costs. ✓ fact
- Pending Mehsana undertaking. Mehsana offers an additional manufacturing and customer platform, subject to completion and subsequent profit disclosure. ⚠ estimate

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown. (Our read after the April to June 2026 results, written 10 October 2026.)

## What could change the Foseco India story? What are the risks? Conversely, operating-profit deterioration after the acquisition becomes comparable, without integration savings offsetting margin normalization, would invalidate the operating expansion thesis. ### Each change stops working if

- Acquired crucible platform: Acquired earnings fail to offset the 18.02% increase in parent shares and recurring integration costs. - Pending Mehsana undertaking: Approvals delay completion or integration fails to produce disclosed incremental attributable earnings. ### The main risks

- : Acquisition costs, provisions and reversals complicate the earnings bridge. ⚠ estimate
- : The acquisition increased parent shares by 18.02%, so consolidated profit growth alone cannot establish accretion. ⚠ estimate
- : The asset-base increase must not be mistaken for cash spent commissioning production capacity. ⚠ estimate
- : The proposed Mehsana acquisition has a pending deadline and no quantified earnings contribution. ⚠ estimate

(Our read after the April to June 2026 results, written 10 October 2026.)

## What to watch in Foseco India's next results? When Foseco India reports July to September 2026, these are the 6 checks that show whether the story is still on course. First: Operating margins decline toward 15% without enough revenue growth to preserve operating profit. - What to check ()
- Operating margins decline toward 15% without enough revenue growth to preserve operating profit. - Reported profit improves while operating profit or attributable earnings per share deteriorate. - Consolidated profit grows while attributable earnings per parent share fail to improve. - A latest-period filing identifies promoter share disposals beyond mechanical dilution. - Acquisition-related asset additions are presented as self-funded capacity spending without a cash-flow reconciliation. - The Mehsana deadline passes without a completion disclosure or an explained extension. ## Which stock lists is Foseco India on? Foseco India is not on any of our India lists this week. ## Is Foseco India profitable? Foseco India Ltd earned ₹23.0 Cr of net profit in the Jun 2026 quarter, +4.5% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY25 profit was ₹75.0 Cr. Over 10 years profit has grown 8.9% a year on average. That is 12.6% of the quarter's revenue. The same quarter a year earlier earned ₹22.0 Cr. For the full year, FY25 profit was ₹75.0 Cr (+2.7% on the year before). Why profit moved: revenue changed +15.9% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −5.5% and revenue +10.3%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Foseco India make, and is it growing? Foseco India Ltd reported ₹182 Cr of revenue in the Jun 2026 quarter, +15.9% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 7.5% a year on average. The last full year, FY25, came in at ₹604 Cr. The last four reported quarters add to ₹644 Cr. FY25 revenue was ₹604 Cr, +15.0% on the year before. Recent pace: the last four quarters grew +10.3% on average, against 7.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +10.5%, against +14.3% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −4.8%, against +10.2% a year (rolling over). ## How much of every ₹100 of sales does Foseco India keep? Foseco India Ltd's operating margin was 18.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 12 years it has been between 8.0% and 18.0%. The latest quarter is within that range. Across 12 years it has been between 8.0% and 18.0%, and FY25's 18.0% is the highest of them. Why the margin moved: operating margin changed +0.5 percentage points on the year while gross margin changed +1.1 points. So the gain came mostly from the gross margin, which means input costs and prices charged. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Foseco India's profit turning into cash? Over the last 3 years, 86% of Foseco India Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in ₹92.0 Cr of operating cash against ₹75.0 Cr of profit. After ₹8.0 Cr of spending on assets, ₹84.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 86% of profit came in as cash: the cash cycle stayed about the same between FY20 and FY25, so the cash follows profit, not the cycle. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Foseco India's cash go? Foseco India Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −39 days in FY25, up from −46 days in FY20. It spent ₹41.0 Cr on assets over the last 3 years. Customers take 77 days to pay, and stock sits for 39 days on average. At FY25 sales of ₹604 Cr, each day of that cycle ties up about ₹1.7 Cr, so roughly −₹65.0 Cr is tied up in the business at any time. FY25: customers took 77 days to pay and stock sat for 39 days, about 1.3 months of sales sitting as stock, for a full cycle of −39 days, longer than FY20's −46. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 39 days. Customers pay about 77 days after that. Suppliers are paid at 156 days. Together that makes the −39-day cycle. Spending on assets: ₹41.0 Cr over the last 3 years, against ₹28.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹2.0 Cr (FY25): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Foseco India's P/E ratio, and how does it compare with its own history? Foseco India Ltd's P/E is 51.2×, near the high end of its own history: higher than 95% of past readings. Its usual P/E (the middle reading) is 32.2×, over 10 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹108.54. Why the multiple is where it is: over the past year earnings per share moved −12.7% while the price moved +8.5%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +32.0% a year; about +18.6% a year came from earnings growth and about +13.4 percentage points from the multiple (the market paying more); over 10 years the price moved +15.6% a year; about +8.3% a year came from earnings growth and about +7.3 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Foseco India business getting better or worse? Foseco India Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −4.8% in the latest quarter, against +64.3% at its best in 12 quarters, with ROCE falling at 13.9%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## What is the Foseco India story, and has it been checked? Foseco India Ltd's story is not scored yet against the checks our research set on 10 October 2026. Where it sits in its own cycle: MID EXPANSION. Our read, 10 October 2026. From the numbers. The current weekly classification comes from pe pb cycle because pe cycle current is null. Elevated…

From the price. Price stage 2, week 18, above its 200-day line, relative strength falling. From the research. Where they disagree. The current weekly classification comes from pe pb cycle because pe cycle current is null. Elevated margins inflate the earnings denominator relative to normalization. What is proven. What is not proven yet. Conversely, operating-profit deterioration after the acquisition becomes comparable, without integration savings offsetting margin normalization, would invalidate the operating expansion thesis. What would change our mind. Conversely, operating-profit deterioration after the acquisition becomes comparable, without integration savings offsetting margin normalization, would invalidate the operating expansion thesis. What the company does. Operating profit has increased, while acquisition costs and subsequent accounting adjustments complicate the reported earnings comparison. The completed crucible acquisition provides an operating platform; the proposed Mehsana transaction remains a pending addition rather than delivered earnings. What the surface reading misses. The surface reading is: The latest operating result appears better than the preceding quarter. The research reads it further: Operating profit increased alongside revenue, but the acquired reporting perimeter prevents the total from establishing organic demand or pricing gains. What the surface reading misses. The surface reading is: Reported profit growth appears to show acceleration. The research reads it further: Operating profit also grew, but subsidiary inclusion and a provision reversal mean reported growth is not a clean organic or attributable per-share comparison. Sources: our stock research file (10 October 2026) · quarterly results through Jun 2026. The story check is re-scored every results season; the record below never changes. ## How much does Foseco India earn on its capital? Foseco India Ltd earned a ROCE of 16% in FY25. That is up from a low of 12% in FY20. Its return on capital used (ROIC) is 0.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 12.4% net margin and 0.50× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 12.4% net margin × 0.50× asset turnover × 1.16× leverage (assets divided by equity) ≈ 7.2% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 12.8% − 12.0% = +0.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 12.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 14.4%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Foseco India have too much debt? Foseco India Ltd has total debt of ₹2.0 Cr against shareholder equity of ₹1,163 Cr as of Jun 2026, so its debt is 0.00× its equity, which is very little. Year by year, that ratio went from 0.00 in FY24 to 0.00 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Foseco India shareholding pattern? Domestic institutions raised their stake in Foseco India Ltd by 13.2 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 13.5% of the company. Promoters moved −11.4 points over the same period, to 63.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: +13.2 points over 8 quarters, to 13.5%; Promoters: −11.4 points over 8 quarters, to 63.5%; Foreign institutions: +0.9 points over 8 quarters, to 1.0%. Why the owners changed: domestic institutions drove it (+13.2 points), with the other side taken by promoters (−11.4 points). They raised their stake step by step. ## How far is Foseco India from balance-sheet trouble? For Foseco India Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Foseco India rank in its industry? 41.1 out of 100, rank 14 of 20 in Chemicals - Organic, with 81% of the evidence available. Foseco India Ltd scores 41.1 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 14. A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. The four parts add up to the total exactly: 11.5 + 16.4 + 1.8 + 11.4 = 41.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Foseco India compared with? Foseco India ranks 14 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 41.1 out of 100. 1. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) NITTAGELA · quiet · Most evidence points up · 85% evidence 76.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 15% · Profit 49.4% · Operating margin change 9 points · 100% evidence Capital efficiency 21.3/25 · ROCE 27.7% · Operating margin 28% · 100% evidence Valuation 13.2/20 · P/E 12.1× · PEG 0.95 · 100% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 35.5% · 1 year n/a · 25% evidence · 5 of 12 weeks ahead Exact sum: 30.4 + 21.3 + 13.2 + 12 = 76.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) INDOAMIN · losing its lead · Most evidence points up · 81% evidence 66.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 13.3% · Profit 24.2% · Operating margin change 3 points · 88% evidence Capital efficiency 16.8/25 · ROCE 18.9% · Operating margin 14% · 100% evidence Valuation 19.0/20 · P/E 10.6× · PEG 0.32 · 100% evidence Relative strength 9.5/20 · Lead over its industry n/a · Lead over NIFTY 500 2.3% · 1 year -10.4% · 25% evidence · 4 of 12 weeks ahead Exact sum: 20.8 + 16.8 + 19 + 9.5 = 66.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) VALIANTORG · breaking out · Evidence leans up · 78% evidence 61.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 1.5% · Profit 100% · Operating margin change 6 points · 83% evidence Capital efficiency 9.0/25 · ROCE 5.5% · Operating margin 18% · 76% evidence Valuation 10.9/20 · P/E 23.2× · PEG n/a · 50% evidence Relative strength 19.8/20 · Lead over its industry 24.1% · Lead over NIFTY 500 48.6% · 1 year 39.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 21.4 + 9 + 10.9 + 19.8 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) OCCLLTD · breaking out · Too little evidence to rank firmly · 56% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 40.6% · Profit 100% · Operating margin change 7 points · 83% evidence Capital efficiency 12.3/25 · ROCE 13% · Operating margin 28% · 76% evidence Valuation 11.1/20 · P/E 11× · PEG n/a · 15% evidence Relative strength 12.1/20 · Lead over its industry n/a · Lead over NIFTY 500 45.3% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.6 + 12.3 + 11.1 + 12.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [BASF India Ltd](https://www.sectoralpha.in/stocks/basf-india-ltd) BASF · quiet · Evidence leans up · 71% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 6.5% · Profit 62.4% · Operating margin change 4 points · 88% evidence Capital efficiency 11.7/25 · ROCE 14.5% · Operating margin 10% · 100% evidence Valuation 14.1/20 · P/E 21.4× · PEG n/a · 50% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -13% · 1 year -30.9% · 25% evidence · 5 of 12 weeks ahead Exact sum: 23.8 + 11.7 + 14.1 + 7.7 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ELANTAS · leader · Evidence leans up · 67% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 18.7% · Profit 35.5% · Operating margin change 1 points · 95% evidence Capital efficiency 18.1/25 · ROCE 21.2% · Operating margin 23% · 76% evidence Valuation 6.5/20 · P/E 54.1× · PEG n/a · 50% evidence Relative strength 11.8/20 · Lead over its industry n/a · Lead over NIFTY 500 31.9% · 1 year 33.1% · 25% evidence · 12 of 12 weeks ahead Exact sum: 20.7 + 18.1 + 6.5 + 11.8 = 57.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) FINEORG · leader · Evidence leans up · 96% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 7.1% · Profit 5.8% · Operating margin change 4 points · 88% evidence Capital efficiency 17.8/25 · ROCE 21.5% · Operating margin 25% · 100% evidence Valuation 15.0/20 · P/E 35.3× · PEG 0.58 · 100% evidence Relative strength 9.9/20 · Lead over its industry -7.6% · Lead over NIFTY 500 12.4% · 1 year 13.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 13.9 + 17.8 + 15 + 9.9 = 56.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) LXCHEM · quiet · Evidence leans up · 81% evidence 54.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 5.5% · Profit 26% · Operating margin change 7.6 points · 88% evidence Capital efficiency 10.8/25 · ROCE 4.7% · Operating margin 12% · 100% evidence Valuation 13.1/20 · P/E 33.8× · PEG 1.14 · 100% evidence Relative strength 9.2/20 · Lead over its industry n/a · Lead over NIFTY 500 1.8% · 1 year -22% · 25% evidence · 10 of 12 weeks ahead Exact sum: 21.1 + 10.8 + 13.1 + 9.2 = 54.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) BALAMINES · quiet · Evidence leans up · 78% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 11.1% · Profit 41.6% · Operating margin change 10 points · 83% evidence Capital efficiency 13.1/25 · ROCE 11% · Operating margin 25% · 76% evidence Valuation 9.1/20 · P/E 28× · PEG n/a · 50% evidence Relative strength 8.2/20 · Lead over its industry -2.5% · Lead over NIFTY 500 15.2% · 1 year 25.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 23.2 + 13.1 + 9.1 + 8.2 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) FAIRCHEMOR · quiet · Evidence leans up · 100% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.3/35 · Revenue 17.1% · Profit 100% · Operating margin change 6.2 points · 100% evidence Capital efficiency 7.0/25 · ROCE 3.3% · Operating margin 10% · 100% evidence Valuation 13.0/20 · P/E 32.7× · PEG 0.84 · 100% evidence Relative strength 3.0/20 · Lead over its industry -15.4% · Lead over NIFTY 500 3.2% · 1 year -15.9% · 100% evidence · 9 of 12 weeks ahead Exact sum: 30.3 + 7 + 13 + 3 = 53.3 · What this means: Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%. 11. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) SIGACHI · breaking out · Evidence leans down · 100% evidence 49.4 out of 100 Growth Capital Valuation Relative
12. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) GFLLIMITED · breaking out · Evidence leans down · 71% evidence 48.6 out of 100 Growth Capital Valuation Relative
13. [Jyoti Resins and Adhesives Ltd](https://www.sectoralpha.in/stocks/jyoti-resins-and-adhesives-ltd) JYOTIRES · basing · Evidence leans down · 74% evidence 43.7 out of 100 Growth Capital Valuation Relative
14. Foseco India Ltd this page FOSECOIND · leader · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.5/35 · Revenue 10.5% · Profit -4.8% · Operating margin change 1 points · 88% evidence Capital efficiency 16.4/25 · ROCE 16.4% · Operating margin 18% · 100% evidence Valuation 1.8/20 · P/E 50.3× · PEG 2.42 · 100% evidence Relative strength 11.4/20 · Lead over its industry n/a · Lead over NIFTY 500 17% · 1 year 2.7% · 25% evidence · 11 of 12 weeks ahead Exact sum: 11.5 + 16.4 + 1.8 + 11.4 = 41.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 15. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) SGRL · breaking out · Evidence leans down · 85% evidence 40.3 out of 100 Growth Capital Valuation Relative
16. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) OAL · leader · Evidence leans down · 74% evidence 36.5 out of 100 Growth Capital Valuation Relative
17. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) GEMAROMA · quiet · Too little evidence to rank firmly · 51% evidence 32.2 out of 100 Growth Capital Valuation Relative
18. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) SACHEEROME · losing its lead · Too little evidence to rank firmly · 36% evidence 58.1 out of 100 Growth Capital Valuation Relative
19. [Shri Ahimsa Naturals Ltd](https://www.sectoralpha.in/stocks/shri-ahimsa-naturals-ltd) SHRIAHIMSA · leader · Too little evidence to rank firmly · 47% evidence 56.8 out of 100 Growth Capital Valuation Relative
20. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) CITURGIA · Too little evidence to rank firmly · 25% evidence 34.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Organic](https://www.sectoralpha.in/sectors/chemicals-organic), all 20 compared on one page. ## Which companies are close to Foseco India in size? Foseco India is the 5th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: BASF India, Elantas Beck India and Balaji Amines. Just below it: Laxmi Organic Industries, Oriental Aromatics and Nitta Gelatin India. ### Chemicals - Organic companies close in size

1. [BASF India Ltd](https://www.sectoralpha.in/stocks/basf-india-ltd) ₹13,198 crore
2. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ₹6,417 crore
3. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) ₹5,721 crore
4. Foseco India Ltd ₹4,419 crore
5. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) ₹4,245 crore
6. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) ₹1,916 crore
7. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) ₹1,489 crore

[All 20 Chemicals - Organic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-organic#all-companies)

### Companies close in size in other industries

1. [Surya Roshni Ltd](https://www.sectoralpha.in/stocks/surya-roshni-ltd) ₹4,436 crore · Steel - Tubes/Pipes
2. [Mastek Ltd](https://www.sectoralpha.in/stocks/mastek-ltd) ₹4,433 crore · IT - Software
3. Foseco India Ltd ₹4,419 crore
4. [63 Moons Technologies Ltd](https://www.sectoralpha.in/stocks/63-moons-technologies-ltd) ₹4,372 crore · IT - Software
5. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) ₹4,369 crore · Pesticides/Agrochemicals

## What else do people ask about Foseco India? ### What is Foseco India's share price today? Foseco India Ltd's share price is ₹5,969.00, +8.5% over the past year. The whole company is worth ₹4,498 Cr on the market. In the last 52 weeks it traded between ₹4,386 to ₹6,678; today it is 69% of the way up from the low, 8.9% above its 200-day average (as of 4 November 2026). ### What were Foseco India's latest quarterly results? Foseco India Ltd reported revenue of ₹182 Cr and net profit of ₹23.0 Cr for the Jun 2026 quarter. Revenue rose 15.9% and profit rose 4.5% compared with a year earlier. Earnings per share were ₹30.33. The operating margin was 18.0%, 1.0 percentage points higher than a year earlier (as of 4 November 2026). ### What is Foseco India's market cap? Foseco India Ltd's market capitalisation is ₹4,498 Cr at a share price of ₹5,969.00. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Foseco India performing? Foseco India Ltd's share price has been rising for 18 weeks. In its latest quarter, revenue rose 15.9% and profit rose 4.5% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 17 weeks running (as of 4 November 2026). ### Will Foseco India's share price go up? This page does not forecast Foseco India Ltd's share price. What it shows instead: the share price is ₹5,969.00, and it has been rising for 18 weeks. Its P/E of 51.2× is higher than 95% of its own last 10 years (as of 4 November 2026). ### Who owns Foseco India? Promoters own 63.5% of Foseco India Ltd, foreign institutions 1.0%, domestic institutions 13.5% and the public 21.9% (latest quarter). The biggest change over the last two years: Domestic institutions raised their stake by 13.2 percentage points over 8 quarters (as of 4 November 2026). ### Does Foseco India have too much debt? No, Foseco India Ltd has little debt: its debt is 0.00× its equity, and its operating profit is 55 times its interest bill. FY25 borrowings were ₹1.0 Cr against equity of ₹1,040 Cr. So the returns on this page come from the business, not borrowed money (as of 4 November 2026). ### Where is Foseco India in its business cycle? Foseco India Ltd's FY25 operating margin was 18.0%, against a 12-year range of 8.0% to 18.0%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 18.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Foseco India story? The main question: results are strong, and the P/E is higher than 95% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Foseco India a stock worth studying right now? What the numbers show: Foseco India Ltd's results are improving, and its P/E is near the top of its own history, higher than 95% of past readings. The main open question: whether earnings grow enough to match the multiple. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a Foseco India share price forecast for 2026? What is changing at Foseco India, from the latest results and calls: acquired crucible platform and pending mehsana undertaking. What would change the story: Conversely, operating-profit deterioration after the acquisition becomes comparable, without integration savings offsetting margin normalization, would invalidate the operating expansion thesis. This is research, not advice. We’re not SEBI-registered.